Charles Buchen, MD
About Charles Buchen, MD
Charles Buchen, MD, serves as the Vice President of Business Development at Mustang Bio, where he has worked since 2021. He has extensive experience in developing cell and gene therapies and has previously held leadership roles at Baergic Bio Inc and Fortress Biotech.
Work at Mustang Bio
Charles Buchen serves as the Head of Business Development at Mustang Bio since 2021. In this role, he has led the expansion of the company's pipeline, focusing on the in vivo CAR platform and gene therapies aimed at treating rare diseases. His contributions have been significant in advancing Mustang Bio's clinical and early-stage development candidates, enhancing the company's position in the biotechnology sector.
Work at Fortress Biotech
Charles Buchen has been with Fortress Biotech since 2018, currently holding the position of Vice President, Business Development. His tenure at Fortress has spanned six years, during which he has contributed to the strategic direction of the company. Prior to his current role, he served as Director at Fortress Biotech from 2015 to 2018, where he gained valuable experience in business development within the biotechnology industry.
Experience at Baergic Bio Inc
Before joining Mustang Bio, Charles Buchen was the Founder of Baergic Bio Inc, where he worked from 2019 to 2022. His experience in founding and leading a biotechnology company has provided him with a comprehensive understanding of the industry and the challenges associated with developing innovative therapies.
Education and Expertise
Charles Buchen earned his Doctor of Medicine (M.D.) degree from Albert Einstein College of Medicine. He also holds a Bachelor of Arts (B.A.) from Brooklyn College. His educational background has equipped him with the knowledge and skills necessary for his roles in business development and the advancement of cell and gene therapies, particularly for hematologic cancers and solid tumors.